BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform

BioStem Life Sciences has signed a Master Service Agreement with a new customer to manufacture the customer’s amniotic membrane platform for the next two years
Read MoreRead More

BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020

BioStem Technologies announced that it expects to file its annual and quarterly reports for the years 2018, 2019, and 2020 to become current with OTC Markets in late 2020.
Read MoreRead More

BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)

BioStem Life Sciences has been awarded the prestigious accolade of accreditation by the American Association of Tissue Banks® (AATB®)
Read MoreRead More

HCPCS Q-Codes for Medicare & Medicaid Services (CMS)

BioStem Technologies today announced the submission of applications for three of its dehydrated placental membrane allograft products to the Centers for Medicare and Medicaid Services (CMS), in process to be granted Q-Codes.
Read MoreRead More

Tissue Bank Certification News in California & Maryland

BioStem Life Sciences has added California and Maryland to its list of tissue bank licenses issued by the individual state’s Department of Health.
Read MoreRead More

Are you interested in working with us?

If you have questions about the company, our lab, our scientific team or anything else, please feel free to contact us.

Contact Us

Contact Information
(954) 380-8342

2836 Center Port Circle
Pompano Beach, FL 33064


Social Media


Terms of UsePrivacy Policy

© 2020 BioStem Life Sciences, a subsidiary of BioStem Technologies. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.